Cegedim (ALCGM) AI Stock Analysis

• Market Cap: €172.80M
• Dividend Yield: N/A
• Average Volume (3M): 11.58K
• Price to Earnings (P/E): 18.4
• Beta (1Y): 0.62
• Revenue Growth: 3.79%
• EPS Growth: -797.10%
• Country: FR
• Employees: 6,605
• Sector: Technology
• Sector Strength: 88
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.60
• Shares Outstanding: 14,097,155
• 10 Day Avg. Volume: 10,897
• 30 Day Avg. Volume: 11,578
• PEG Ratio: -0.12
• Price to Book (P/B): 0.66
• Price to Sales (P/S): 0.27
• P/FCF Ratio: 14.63
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €14.00
• Price Target Upside: 29.63% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1
• EPS Forecast (FY): 1.79
• Revenue Forecast (FY): €685.11M

• Rating: 60 Neutral
• Price Target: €14.50 ▲(34.26% Upside)
• Action: Reiterated Date: 10/25/25
• Date: Action: Reiterated 10/25/25

Cegedim's overall stock score is primarily influenced by its solid revenue growth and strong technical momentum. However, challenges with profitability, financial stability, and valuation concerns due to a negative P/E ratio and lack of dividend yield weigh down the score. The absence of earnings call data and corporate events means these factors did not influence the score.

Positive Factors

Business model diversification

Multiple, complementary revenue streams (subscriptions, transaction fees, consulting and data services) create durable cash inflows and reduce reliance on any single customer or product. This mix supports predictable recurring revenue and resilience through sector cycles in healthcare IT.

Negative Factors

Negative profitability

Recurring negative net income and shrinking EBIT margins threaten long-term sustainability; without margin recovery, the firm may struggle to self-fund R&D and growth initiatives, risking dilution or debt-funded expansion to maintain competitiveness.

Cegedim Business Overview & Revenue Model

Company Description

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B in France, rest of Europe, and internationally. It operates through Health Insurance, HR and E-Services; Healthc...

Read more

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B in France, rest of Europe, and internationally. It operates through Health Insurance, HR and E-Services; Healthc...

How the Company Makes Money

Cegedim generates revenue through multiple streams, primarily by providing software solutions and data services to healthcare organizations and pharmaceutical companies. Key revenue models include subscription fees for software licenses, transacti...

Read more

Cegedim generates revenue through multiple streams, primarily by providing software solutions and data services to healthcare organizations and pharmaceutical companies. Key revenue models include subscription fees for software licenses, transacti...

Cegedim Financial Statement Overview

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	654.50M	616.00M	555.21M	524.71M	496.94M
Gross Profit	624.93M	255.63M	528.65M	498.01M	471.45M
EBITDA	101.56M	95.25M	94.96M	103.64M	60.71M
Net Income	-14.71M	-7.41M	13.62M	26.22M	10.84M
Balance Sheet
Total Assets	986.89M	924.07M	889.91M	797.59M	905.36M
Cash, Cash Equivalents and Short-Term Investments	49.58M	46.61M	55.55M	24.16M	24.73M
Total Debt	325.85M	285.10M	284.59M	275.50M	266.46M
Total Liabilities	704.39M	629.51M	585.78M	565.20M	697.45M
Stockholders Equity	264.35M	276.18M	285.16M	232.06M	207.66M
Cash Flow
Free Cash Flow	11.93M	22.43M	10.34M	45.23M	35.85M
Operating Cash Flow	101.85M	97.92M	86.48M	95.98M	110.38M
Investing Cash Flow	-111.32M	-75.30M	-20.17M	-70.11M	-69.26M
Financing Cash Flow	13.12M	-31.07M	-33.89M	-26.74M	-45.20M

Cegedim Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 10.80
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALCGM, the sentiment is Positive. The current price of 10.8 is above the 20-day moving average (MA) of 10.32, below the 50-day MA of 11.62, and below the 200-day MA of 11.57, indicating a bullish trend. The MACD of 0.10 indicates Negative momentum. The RSI at 68.46 is Neutral, neither overbought nor oversold. The STOCH value of 98.62 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:ALCGM.

Cegedim Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
COH	73 Outperform	€66.24M	6.23	18.06%	0.55%	6.71%	7.79%
AUB	72 Outperform	€559.34M	19.04	12.71%	2.54%	1.02%	6.31%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
ALCGM	60 Neutral	€172.80M	18.44	-5.44%	―	3.79%	-797.10%
BLC	49 Neutral	€175.51M	1.50	3.97%	―	-7.28%	―
ATO	41 Neutral	€695.00M	-0.69	319.82%	―	-14.60%	―
ALINS	41 Neutral	€10.48M	-1.12	-4411.84%	―	13.56%	-65.50%